MedTrace Logo

Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome.

NCT05119127 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2021-11-12

No results posted yet for this study

Summary

The purpose of this research is to assess the rotational stability of the AcrySof IQ Vivity Extended Vision Toric IOL and Refractive Visual outcome.

Conditions

  • Cataract

Interventions

DEVICE

Alcon Vivity toric intra ocular lens

implanting vivity toric IOL to asses rotational stability. IOL is already FDA approved for implantation at time of cataract surger. Intervention is to assess rotational stability and visual outcome.

Sponsors & Collaborators

  • Alcon Research

    collaborator INDUSTRY

  • Eric Rosenberg, D.O.,M.Sc.Eng.

    collaborator UNKNOWN

  • Kevin Barber

    lead OTHER

Principal Investigators

  • Kevin Barber, MD · Ophthalmologist

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-30
Primary Completion
2021-05-05
Completion
2021-08-19

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05119127 on ClinicalTrials.gov